Kazakhstan’s pharmaceutical market is worth $800 million. A major portion of this, up to 80% by some estimates, is by imports. Hence, Kazakhstan remains a very attractive market for foreign companies. Alkem operates in Kazakhstan through its subsidiary, The Pharma Network (TPN), setup in 2011.
In a relatively short period, we made our presence felt! Today, we are amongst the top 5 Indian companies in the prescription market (Viortis 2018). We have a strong presence in anti-infective market with the leadership position in Cefixime. In addition, we rank amongst the top 5 in Pantoprazole, Co-amoxiclav and Cefuroxime markets.
Standing on this solid foundation, we are poised to increase our prescription base by entering the chronic segment.
Contact Us :
The Pharma Network LLP, Seyfullin Avenue,
Intersection of Mametova - 404/67/9,
Almaty. Republic of Kazakhstan.
E-mail ID : email@example.com